285.2 𩺠åèç
285.2.1 é«é »èé»
285.2.1.1 AS Severity (Echo)
- Peak vel ⥠4 m/s
- Mean gradient ⥠40 mmHg
- AVA †1.0 cm² (or †0.6 indexed)
285.2.1.2 AS Stages (ACC/AHA 2020)
- A (at risk) â B (progressive) â C (asymptomatic severe; C1 normal LV, C2 LV dysfunction) â D (symptomatic severe; D1 high-grad, D2 low-flow low-grad reduced EF, D3 paradoxical low-flow preserved EF)
285.2.1.3 Dobutamine Stress Echo (for low-flow, low-grad)
- True severe AS: increasing gradient with stable area
- Pseudosevere AS: increase in area with flow recovery
- No contractile reserve: poor prognosis
285.2.1.4 AS Surgical/TAVR Indications
- Symptomatic severe AS (any flow pattern)
- Asymptomatic severe + LV dysfunction (EF < 50%)
- Asymptomatic severe + abnormal stress test
- Asymptomatic + very severe (peak vel ⥠5)
- Asymptomatic + cardiac surgery for other reasons
- EARLY-TAVR 2024: select asymptomatic severe â early TAVR
285.2.1.5 AS Key Trials
- PARTNER 1A/B (inoperable, high-risk): TAVR established
- PARTNER 2/3, SURTAVI: intermediate / low risk
- EARLY-TAVR 2024: asymptomatic severe AS
285.2.1.6 AR Surgical Indications
- Symptoms (NYHA II-IV)
- LV EF < 55% (Class I)
- LVESD > 50 mm or indexed > 25 mm/m² (Class I)
- LVEDD > 65 mm (Class IIa some)
- Aortic root > 5.0-5.5 cm
285.2.2 ææ··æ·æ¯èŒ
| Feature | AS | AR (chronic) | AR (acute) |
|---|---|---|---|
| Murmur | Systolic crescendo-decrescendo R 2nd ICS | Diastolic decrescendo LSB sitting forward | Often soft / no murmur |
| Pulse | Parvus et tardus | Bounding, wide PP | Narrow, weak |
| LV | Concentric LVH | Eccentric, dilated | Normal-sized, â EDP |
| Symptoms | SAD; sudden post-symptom | Slow progression | Acute decompensation |
| Treatment | TAVR/SAVR if symptomatic, severe | AVR if symptoms or LV dysfunction | Emergency surgery |